Five major takeaways from Roche’s $5B acquisition of Spark Therapeutics

Five major takeaways from Roche’s $5B acquisition of Spark Therapeutics

STAT Plus: Here are five immediate takeaways from Roche’s $5 billion acquisition of Spark Therapeutics

By MATTHEW HERPER

VANESSA BUMBEERS/UNSPLASH

The proposed deal means that large pharma companies are on a full-fledged buying spree, and that gene therapy, has made the big time.

READ MORE